Paroxetine Tablet, Film Coated
Product Images NDC 60505-0084

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 60505-0084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg-30s-btl.jpg (10mg 30s Btl)

Paroxetine 10 mg tablets label shows a 30 count package of film-coated oral tablets. The label states 'Paroxetine Tablets, USP' with strength 10 mg prominently displayed. It includes storage instructions, dispensing precautions, and manufacturing details by Apotex Inc., Toronto, Canada, for Apotex Corp., Weston, Florida. A barcode and NDC 60505-0097-1 are visible.*

FDA Label Image

20mg-30s-btl.jpg (20mg 30s Btl)

Paroxetine Tablets USP 20 mg film-coated tablets packaging label from Apotex Corp. The label indicates a package size of 30 tablets. It includes storage instructions, manufacturer and distributor information, and a barcode. The NDC number 60505-0083-1 is visible on the label.*

FDA Label Image

30mg-30s-btl.jpg (30mg 30s Btl)

Paroxetine 30 mg tablets packaging label from Apotex Corp. The label shows the product name Paroxetine Tablets USP, strength 30 mg, and a count of 30 tablets. It includes storage instructions and a note to dispense with a Medication Guide. The label also provides manufacturer and distributor details along with a barcode and NDC 60505-0084-1.*

FDA Label Image

40mg-30s-btl.jpg (40mg 30s Btl)

Label for Paroxetine Tablets, USP 40 mg by Apotex Corp. The label indicates 30 tablets per container and provides storage instructions at 20°C to 25°C with permitted excursions. It includes manufacturer details, a barcode, and a note for pharmacists to dispense with the medication guide from Apotex's website.*

FDA Label Image

Figure1

A pharmacokinetic chart showing fold change and 90% confidence intervals for Cmax and AUC values relative to a reference for various interacting drugs including Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The x-axis is a logarithmic scale representing change relative to reference, ranging from 0.1 to 10.0.*

FDA Label Image

Figure2

A chart displaying fold changes and 90% confidence intervals for the pharmacokinetic parameters Cmax and AUC of paroxetine when taken with various interacting drugs. The x-axis shows change relative to a reference value of 1, with data points for Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam at different dosages.*

FDA Label Image

Figure3

A pharmacokinetic (PK) fold change graph with 90% confidence intervals showing Cmax, Cmin, and AUC values for paroxetine hydrochloride under different population conditions including renal impairment (mild, moderate, severe), hepatic impairment, age over 65 with varying doses (20 mg, 30 mg, 40 mg once daily), and gender (males). The horizontal axis represents change relative to reference on a logarithmic scale from 0.5 to 50.*

FDA Label Image

Structure

Chemical structure of paroxetine hydrochloride, the active ingredient in PAROXETINE tablets, showing its molecular framework including fluorophenyl and dioxolane groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.